Core Viewpoint - OneMedNet Corporation has successfully completed a private placement, raising approximately $4.6 million, which will be used for working capital and general corporate purposes, including a significant investment in Bitcoin [1][2][3]. Group 1: Private Placement Details - The private placement involved securities purchase agreements with institutional investors, including Off the Chain Capital and Discovery Capital Management [1]. - OneMedNet sold 1,297,059 shares at $1.0278 per share and prefunded warrants for 1,323,530 shares at the same price to Off the Chain Capital [2]. - The company also sold 2,301,791 shares at $0.85 per share to Discovery Capital Management [3]. Group 2: Use of Proceeds - The net proceeds from the private placement will primarily be allocated for working capital and general corporate purposes [1]. - The company has already utilized $1.8 million of the net proceeds to purchase Bitcoin [1]. Group 3: Company Overview - OneMedNet Corporation specializes in curating regulatory-grade Real World Data (RWD), including electronic health records, laboratory results, and medical imaging [6]. - The company operates the iRWD™ platform, which manages diverse clinical data types and supports research opportunities for drug, medical device, and AI development customers [6][7]. - OneMedNet's platform is designed to meet clinical requirements across various domains, including rare diseases, oncology, and cardiology [7].

MINNEAPOLIS, July 22, 2024 (GLOBE NEWSWIRE) -- Further to its press release dated June 14, 2024, OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, announced today that Cytel Inc, ("Cytel"), a global leader in clinical trial design and software, has now identified itself as the other party with which OneMedNet recently entered into a iR ...

Core Insights - OneMedNet Corporation has entered into a data license agreement with Cytel Inc, enhancing its capabilities in providing regulatory-grade Real World Data (RWD) for clinical trials [1][2] - The partnership aims to combine OneMedNet's extensive RWD repository with Cytel's advanced analytics, facilitating innovation in trial design and observational studies across various therapeutic areas [2][3] Company Overview - OneMedNet operates a proprietary iRWD™ network that includes over 121 million clinical exams from more than 31 million patients across 1,400 healthcare provider sites [2] - The company specializes in managing diverse clinical data types, including electronic health records, laboratory results, and medical imaging, to support drug and medical device development [5][6] Industry Context - Cytel is recognized as a leader in statistical software and advanced analytics for clinical trial design, with over 1,900 resources globally [4] - The collaboration is expected to enhance the capabilities of both companies in addressing significant health challenges, particularly in areas like oncology and neurologic disorders [3][6]

"This partnership aligns perfectly with OneMedNet's market expansion strategy, and significantly extends our commercial reach within the global life science industry," said Aaron Green, OneMedNet's President and CEO. "Our new partner's recognized expertise in clinical trial design and implementation, combined with our innovative RWD platform, creates a powerful synergy that should help accelerate the development of innovative new medical therapies and technologies targeting some of the world's greatest heal ...

Core Insights - OneMedNet Corporation has entered into a data license agreement with a leading U.S.-based company in clinical trial design, enhancing its market expansion strategy and commercial reach in the life sciences industry [1][2][6] - The partnership aims to leverage OneMedNet's proprietary iRWD™ platform, which manages a diverse set of clinical data, to accelerate the development of new medical therapies and technologies [2][6] - OneMedNet's iRWD™ network includes data from over 1,400 healthcare systems and provider sites, providing significant research opportunities for drug, medical device, and imaging/diagnostic AI development [2][6][8] Company Overview - OneMedNet specializes in regulatory-grade Real World Data (RWD), including electronic health records, laboratory results, and medical imaging [1][2] - The company is committed to enhancing patient outcomes and supporting healthcare innovation across various domains, including rare diseases, oncology, and cardiology [8] - The iRWD™ platform is designed to securely de-identify, search, and curate clinical data, creating a robust funnel of business opportunities for its clients [2][6]

Core Insights - OneMedNet Corporation has joined the Amazon Web Services Partner Network, enhancing its ability to offer regulatory-grade Real World Data to new customers [1][3] - The company has secured a significant new client from the computational biotechnology sector through the AWS Marketplace, indicating strong demand for its iRWD™ services [1][3] Company Overview - OneMedNet specializes in curating regulatory-grade Real World Data, including electronic health records, laboratory results, and medical imaging, from over 1,400 healthcare systems and provider sites [4] - The proprietary iRWD™ platform allows for secure management and curation of diverse clinical data types, facilitating research opportunities for drug, medical device, and AI development customers [4] Strategic Importance - The partnership with AWS is seen as a critical move for OneMedNet, providing access to a broader customer base and enhancing the company's growth potential [3] - The platform is designed to meet clinical requirements across various domains, including rare diseases, oncology, and cardiology, supporting the company's commitment to improving patient outcomes and healthcare innovation [5]

MINNEAPOLIS, June 06, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and medical imaging, is pleased to announce that it has joined the Amazon Web Services ("AWS") Partner Network ("APN") and secured a significant new iRWD™ client, an undisclosed computational biotechnology organization, via the AWS Marketplace. About OneMedNet Corporation ...

MINNEAPOLIS, May 29, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and medical imaging, is pleased to announce that it has entered into a non-exclusive three (3)-year Master Services Agreement ("MSA") with an undisclosed U.S.-based medical technology company that affects more than 150 million patients worldwide annually. Pursuant to the MS ...

Healthcare data management firm OneMedNet (NASDAQ:ONMD) saw its shares skyrocket on Thursday, gaining over 150%. Management recently announced a greater than five-fold expansion of its proprietary data network. In addition, ONMD stock may be riding the coattails of strong industry projections. According to the company's press release, the business expansion concerns the proprietary iRWD network and platform. Short for Real World Data, iRWD is a system that handles a range of clinical data categories, includ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification Number) 6385 Old Shady Oak Road, Suite 250 Eden Prairie, MN 55344 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: 800-918-7189 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Secur ...